Trial Profile
Phase II Trial of FOLFOX in Combination With Cetuximab and Concomitant Radiotherapy in the Treatment of Esophageal Cancer Stage III
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Nov 2017
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Oesophageal cancer
- Focus Therapeutic Use
- Acronyms ERAFOX; FOLFOX
- 30 Mar 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
- 30 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jan 2008 New trial record.